8-132923397-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000220616.9(TG):c.4588C>T(p.Arg1530Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,613,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000220616.9 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TG | NM_003235.5 | c.4588C>T | p.Arg1530Ter | stop_gained | 22/48 | ENST00000220616.9 | NP_003226.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TG | ENST00000220616.9 | c.4588C>T | p.Arg1530Ter | stop_gained | 22/48 | 1 | NM_003235.5 | ENSP00000220616 | P1 | |
TG | ENST00000523756.5 | c.*801C>T | 3_prime_UTR_variant, NMD_transcript_variant | 9/35 | 1 | ENSP00000428628 | ||||
TG | ENST00000519178.5 | c.148C>T | p.Arg50Ter | stop_gained | 2/27 | 2 | ENSP00000430523 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152046Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251390Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135862
GnomAD4 exome AF: 0.000135 AC: 197AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.000149 AC XY: 108AN XY: 727234
GnomAD4 genome AF: 0.000112 AC: 17AN: 152046Hom.: 0 Cov.: 31 AF XY: 0.0000673 AC XY: 5AN XY: 74260
ClinVar
Submissions by phenotype
Iodotyrosyl coupling defect Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2004 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Dec 07, 2022 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | This sequence change creates a premature translational stop signal (p.Arg1530*) in the TG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TG are known to be pathogenic (PMID: 19837936, 23164529). This variant is present in population databases (rs121912646, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with clinical features of thyroid dyshormonogenesis (PMID: 8325944, 11484898, 14764776, 28444304, 33692749, 34248839). This variant is also known as p.Arg1510* and p.Arg1511*. ClinVar contains an entry for this variant (Variation ID: 12691). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 21, 2023 | Published functional studies demonstrate a damaging effect (Targovnik et al., 1993); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 9588493, 8325944, 34200080, 25525159, 11484898, 14764776, 28444304, 34426522, 34248839, 33692749, 35177841) - |
Congenital hypothyroidism Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Polak associated Lab, IMAGINE Institute | - | - - |
Iodotyrosyl coupling defect;C1842444:Autoimmune thyroid disease, susceptibility to, 3 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 28, 2021 | - - |
TG-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 09, 2024 | The TG c.4588C>T variant is predicted to result in premature protein termination (p.Arg1530*). This variant, alternatively referred to as p.Arg1511X using the legacy nomenclature, has been reported in the compound heterozygous state in individuals with congenital hypothyroidism (CH) (see for example, Stoupa et al. 2021. PubMed ID: 33692749; Gutnisky et al. 2004. PubMed ID: 14764776; Targovnik et al. 1998. PubMed ID: 9588493). This variant has also been reported in the heterozygous state in an individual with mild thyroid dyshormonogenesis (Patient 31 in Oliver-Petit et al. 2021. PubMed ID: 34248839); however, the carrier members of a different family for this variant were reported as unaffected (Gutnisky et al. 2004. PubMed ID: 14764776). This variant is reported in 0.015% of alleles in individuals of European (non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at